Good Clinical Practice (GCP) Refresh (R3)

Good Clinical Practice (GCP) Refresh (R3) Training for Professionals

Organised by Avantyo Institute of Clinical Research

Course Description

The GCP (Good Clinical Practice) Refresh R3 course is designed to update and refresh your knowledge on the current ICH-GCP E6 (R3) guidelines and their implementation.

This comprehensive course is meticulously aligned with the latest International Council for Harmonisation (ICH) Good Clinical Practice (GCP) E6 Revision 3 guidance, which was released on January 6, 2025. It is designed to equip clinical research professionals with foundational knowledge and practical insights that can be directly applied to everyday situations in the realm of clinical research.

This course is ideal for professionals who already have a foundational knowledge of GCP and need to stay current with the latest updates. It ensures that participants are well-equipped to conduct clinical trials ethically and effectively, adhering to international standards.

The main objectives of ICH GCP Refresher R3 training include:

• Understand Key Changes: Learn significant updates in ICH GCP E6 R3 guidelines and their impact on clinical trial practices.
• Master Core GCP Principles: Refresh understanding of GCP principles, ethical considerations, and roles of sponsors, investigators, and IRBs.
• Identify New Roles & Responsibilities: Understand expanded roles of clinical trial personnel and best practices for collaboration.
• Navigate Regulatory Framework: Review global regulatory requirements and strategies for ensuring compliance in clinical trials.
• Implement Risk-Based Management: Learn risk-based approaches to clinical trial management and strategies for risk mitigation.
• Ensure Data Integrity & Quality: Discuss the importance of data integrity and quality in clinical research and best practices for accuracy and reliability.
• Facilitating mutual acceptance of clinical trial results: Harmonising standards across different regions to support global collaboration in drug development.
• Promoting transparency and accountability: Encouraging the registration of clinical trials and the reporting of results to maintain public trust.

Why Attend This Good Clinical Practice (GCP) Refresh (R3) Course?

Attending our GCP Refresher R3 course offers numerous benefits for professionals involved in clinical research. Here's why you should consider it:

Comprehensive Curriculum: Our course covers all aspects of GCP, including regulatory requirements, ethical considerations, and practical implementation.

Expert Trainers: Learn from experienced professionals, who bring real-world insights and expertise to the training.

Interactive Learning: Engage in interactive sessions, case studies, and discussions to enhance your understanding and application of GCP principles.

Flexible Learning Options: Attend the course online via Zoom, making it accessible to professionals worldwide.

Stay Updated: The course provides the latest updates on GCP guidelines (ICH E6 R3), ensuring that you're aware of current best practices and regulatory requirements.

Enhance Compliance: Improve your understanding of GCP principles, ensuring that your clinical trials are conducted ethically and in compliance with international standards.

Boost Your Career: Demonstrating a commitment to continuous learning and professional development can enhance your credibility and career prospects in the field of clinical research.

Improve Trial Quality: By staying informed about the latest GCP guidelines, you'll be better equipped to conduct high-quality clinical trials that generate reliable and accurate data.

Networking Opportunities: The course provides an opportunity to connect with other professionals in the field, share experiences, and learn from each other.

Regulatory Readiness: Staying up-to-date with GCP guidelines ensures that you're prepared for regulatory inspections and audits, reducing the likelihood of non-compliance findings.

Participant Profiles

The GCP (Good Clinical Practice) refresh R3 training is designed for a diverse group of participants involved in clinical research. Here are some key profiles of participants who would benefit from this training:

• Clinical Researchers: Individuals conducting clinical trials and research studies, ensuring compliance with GCP guidelines.
• Investigators: Principal investigators and sub-investigators responsible for the conduct of clinical trials at research sites.
• Research Ethics Committee (REC) Members: Members of ethics committees reviewing and approving clinical trial protocols.
• Sponsors: Representatives from pharmaceutical companies, biotech firms, and other organizations sponsoring clinical trials.
• Clinical Research Coordinators: Professionals managing the day-to-day operations of clinical trials at research sites.
• Regulatory Affairs Specialists: Individuals ensuring that clinical trials comply with regulatory requirements and guidelines.
• Monitors and Auditors: Professionals overseeing the conduct of clinical trials and ensuring adherence to GCP standards.
• Data Managers: Individuals responsible for managing and analysing clinical trial data.
• Healthcare Professionals: Doctors, nurses, and other healthcare providers involved in clinical research.

This training is designed to provide participants with an updated understanding of the latest Good Clinical Practice (GCP) guidelines, specifically ICH E6 (R3), ensuring they are fully equipped to conduct clinical trials both ethically and effectively.

Through this comprehensive programme, participants will gain a refreshed and robust knowledge of GCP principles. The training is tailored to enhance their ability to make meaningful contributions to the clinical trials process by cultivating essential skills required to manage the challenges of clinical research. These include navigating ethical considerations, adhering to regulatory requirements, and mastering data management.

By completing this programme, professionals will be thoroughly prepared to excel in their clinical research careers. They will play a pivotal role in advancing medical science and improving patient care, contributing significantly to the development of innovative treatments and therapies.